MARIMED INC. financials

MRMD CIK 0001522767

Source: EDGAR filings · Built 2026-06-19T02:48:34Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 5.21M -6.73M -12.92M -5.06M 17.95M -1.34M
EBITDA 5.29M 10.52M 19.93M 23.80M 29.65M 16.33M
Working Capital 223.00K 3.50M 20.57M 17.66M 17.39M -2.18M
Net Debt 82.33M 89.51M -172.00K 26.11M -5.32M 48.48M
Gross Margin 36.22% 39.70% 44.36% 47.73% 54.55% 61.55%
Operating Margin -1.76% 1.65% 9.68% 15.20% 22.12% 28.55%
Net Margin -9.06% -7.91% -10.79% 10.05% 5.95% 4.21%
Return on Equity (ROE) -28.96% -21.29% -23.27% 23.50% 19.90% 26.47%
Return on Assets (ROA) -7.15% -6.02% -8.17% 8.85% 5.86% 2.80%
Current Ratio 1.00× 1.07× 1.67× 1.67× 1.64× 0.91×
Debt-to-Equity 1.82× 1.65× 0.21× 0.63× 0.67× 6.36×
Effective Tax Rate -33.09% -191.03% -142.68% 30.21% 67.99% 45.97%
Cash Conversion Ratio -0.53× -0.54× -0.49× 0.54× 4.96× 1.58×
Accruals Ratio -0.11× -0.09× -0.12× 0.04× -0.23× -0.02×
SBC % of Revenue 1.16% 0.67% 0.69% 4.73%
CapEx Coverage 3.10× 0.50× 0.38× 0.59× 2.00× 0.72×
Free Cash Flow Per Share $0.01 $-0.02 $-0.04 $-0.01 $0.05 $-0.00

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 159.83M 157.71M 148.60M 134.01M 121.46M 50.90M
Revenues 50.90M
Cost of Revenue 101.94M 95.10M 82.68M 70.05M 55.20M 19.57M
Gross Profit 57.88M 62.61M 65.92M 63.96M 66.26M 31.32M
Operating Expenses 60.70M 60.00M 51.53M 43.59M 39.40M 16.79M
Operating Income (Loss) -2.82M 2.61M 14.38M 20.37M 26.86M 14.53M
Income Tax Expense (Benefit) 3.59M 8.16M 9.41M 5.89M 16.19M 2.07M
Net Income (Loss) Attributable to Parent -14.48M -12.47M -16.03M 13.47M 7.22M 2.14M
Earnings Per Share, Basic $-0.04 $-0.03 $-0.04 $0.04 $0.02 $0.01
Weighted Average Number of Shares Outstanding, Basic 390.13M 379.15M 363.40M 337.70M 326.47M 266.98M
Earnings Per Share, Diluted $-0.04 $-0.03 $-0.04 $0.04 $0.02 $0.01
Weighted Average Number of Shares Outstanding, Diluted 390.13M 379.15M 363.40M 380.29M 372.40M 324.16M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 7.28M 14.64M 9.74M 29.68M 3.00M
Assets, Current 59.29M 53.51M 51.43M 44.15M 44.61M 21.04M
Assets 202.56M 206.99M 196.12M 152.20M 123.20M 76.45M
Long-term Debt 76.04M 78.19M 36.71M
Liabilities, Current 59.07M 50.01M 30.86M 26.49M 27.22M 23.23M
Liabilities 137.83M 129.44M 107.21M 57.17M 49.18M 53.62M
Common Stock, Shares, Outstanding 396.91M 381.48M 375.13M 341.47M 334.03M 314.42M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 7.70M 6.79M 7.91M 7.31M 35.85M 3.38M
Payments to Acquire Property, Plant, and Equipment 1.17M 11.96M 20.13M 12.14M 17.87M 4.69M
Net Cash Provided by (Used in) Investing Activities -1.38M -17.13M -25.98M -26.24M -16.62M -4.46M
Net Cash Provided by (Used in) Financing Activities -4.71M 2.98M 22.98M -1.01M 7.45M 3.34M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (MRMD CIK 0001522767), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

SWDR

Starwood Real Estate Income Trust, Inc.

CHMG

CHEMUNG FINANCIAL CORP

LGNXZ

LIGAND PHARMACEUTICALS INCORPORATED